Jean-Pierre Lindenmayer

Jean-Pierre Lindenmayer, MD

Clinical Professor, Department of Psychiatry

Keywords
Positive and Negative Symptom Scale, Cognitive symptoms of schizophrenia
Summary

Dr. Jean-Pierre Lindenmayer is Director of the Manhattan Schizophrenia Research Program at the Manhattan Psychiatric Center- Nathan Kline Institute for Psychiatric Research, New York, and Clinical Professor, Department of Psychiatry at New York University School of Medicine, New York City. Dr. Lindenmayer’s particular interest has included the development of new pharmacological treatments for schizophrenia and the development of assessment instruments, such as the Positive and Negative Syndrome Scale, which has become the gold standard. He was the first to introduce the syndromal approach in the measurement of schizophrenia psychopathology using the PANSS derived five factor subscales. More recently, he has extended his assessment work in using immersive and non-immersive virtual reality technology in addition to the examination of negative symptoms using AI based speech and facial recordings in order to characterize the digital phenotype of negative symptoms. Dr. Lindenmayer’s work has led to numerous publications in leading scientific journals and presentations at national and international meetings.

Phone

646-766-5866

Academic office

103 Rivers Edge Road, Manhattan Psychiatric Center

15th Floor

New York, NY 10035

Is this your profile?
These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

MD from University of Basel

Fellowship, State University of New York-Downstate Medical Center, Doctor of Medical Sciences Program

Residency, State University of New York-Downstate Medical Center, Psychiatry

Khan, Anzalee; Lindenmayer, Jean-Pierre; Insel, Beverly; Seddo, Mary; Demirli, Ecem; DeFazio, Kayla; Sullivan, Mark; Hoptman, Matthew J; Ahmed, Anthony O

Schizophrenia research. 2023 Jun; 256:117-125

Adam, Ondine; Blay, Martin; Brunoni, Andre R; Chang, Hsin-An; Gomes, July S; Javitt, Daniel C; Jung, Do-Un; Kantrowitz, Joshua T; Koops, Sanne; Lindenmayer, Jean-Pierre; Palm, Ulrich; Smith, Robert C; Sommer, Iris E; Valiengo, Leandro do Costa Lane; Weickert, Thomas W; Brunelin, Jérôme; Mondino, Marine

Schizophrenia bulletin. 2022 Nov 18; 48(6):1284-1294

Nemani, Katlyn; Williams, Sharifa Z; Olfson, Mark; Leckman-Westin, Emily; Finnerty, Molly; Kammer, Jammie; Smith, Thomas E; Silverman, Daniel J; Lindenmayer, Jean-Pierre; Capichioni, Gillian; Clelland, James; Goff, Donald C

JAMA network open. 2022 May 02; 5(5):e2210743

Alphs, Larry; Fu, Dong-Jing; Williamson, David; Jamieson, Carol; Greist, John; Harrington, Magdalena; Lindenmayer, Jean-Pierre; McCullumsmith, Cheryl; Sheehan, David V; Shelton, Richard C; Wicks, Paul; Canuso, Carla M

Innovations in clinical neuroscience. 2022 Apr-Jun; 19(4-6):36-47

Lindenmayer, Jean-Pierre; Burke, Eugene; Tsuboyama, Gabriel; Chahal, Yasmeen; Grewal, Harpreet Kaur

Journal of clinical psychopharmacology. 2022 Jan-Feb 01; 42(1):109-111

Cochran, Jeffrey M; Fang, Hui; Le Gallo, Christophe; Peters-Strickland, Timothy; Lindenmayer, Jean-Pierre; Reuteman-Fowler, J Corey

Patient preference & adherence. 2022 Aug; 16:1805-1817

Cochran, Jeffrey M; Fang, Hui; Sonnenberg, John G; Cohen, Elan A; Lindenmayer, Jean-Pierre; Reuteman-Fowler, J Corey

Neuropsychiatric disease & treatment. 2022 Jul; 18:1521-1534

Lindenmayer, Jean-Pierre; Fitapelli, Brianna

Current opinion in psychiatry. 2021 May 01; 34(3):253-259